FDA's Push For Compounding Oversight Meets Skepticism

Law360, New York (November 21, 2012, 5:51 PM EST) -- Legal and public health experts are skeptical of the U.S. Food and Drug Administration's push for new authority over compounding pharmacies, arguing the FDA could have used its existing power to shut down illegal manufacturers to stop the compounder responsible for a deadly meningitis outbreak.

FDA Commissioner Margaret Hamburg recently appeared before Congress to ask for more legal authority over compounders, which are largely regulated by the states. She proposed creating a category of “nontraditional compounders,” such as those that transport drugs across state lines or...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.